Specialty chemicals company Lanxess has increased its dichlorobenzene capacity by more than 15%. It has done so by installing an additional crystallizer at the Leverkusen site, thereby enabling it to produce more high-purity para-dichlorobenzene for the global market.
Some €3 million has been invested in the capacity expansion for this intermediate for the manufacture of high-performance plastics.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
